The Globe and Mail reports in its Friday, March 6, edition that Stifel analyst Justin Keywood has an unchanged "buy" recommendation on Savaria. The Globe's David Leeder writes in the Eye On Equities column that Mr. Keywood boosted his share target by a loonie to $29. Analysts on average target the shares at $30.50. Mr. Keywood says in a note: "The next iteration of Savaria One will be revealed at the Investor Day, April 14, where new targets are to be conveyed but anticipated to be growth-tilted vs. margin-focused (albeit still expansion opportunity). Organic growth progression is expected throughout 2026 with secular strength, new product introductions and a Europe leadership change. The pipeline for M&A is also robust, both dealer assets and product opportunities with a strong balance sheet to support (only 1 times levered). As Savaria continues to execute well with new scale ahead, valuation should rerate toward peers." The Globe reported on Aug. 22 and Jan. 15 that Mr. Keywood was keeping his "buy" call on Savaria intact. The shares could then be had for $21.15 and $24.92. The Globe reported on Jan. 20 that Scotia Capital analyst Jonathan Goldman viewed Savaria as a top pick. The shares were then going for $25.46.